This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
Manufacturing
Medicinal and Botanical Manufacturing
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, Dravet syndrome, and Lennox-Gastaut syndrome, as well as in phase III clinical trials for the treatment of tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of for schizophrenia, autism spectrum disorder, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Show more...
CEO
Justin Gover
Employees
1161
Country
United Kingdom
Listings
0 Comments
Share your thoughts
FAQ
What is GW Pharmaceuticals stock price today?▼
The current price of GWPH is $218.96 USD — it has increased by +0% in the past 24 hours. Watch GW Pharmaceuticals stock price performance more closely on the chart.
What is GW Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GW Pharmaceuticals stocks are traded under the ticker GWPH.
What is GW Pharmaceuticals market cap?▼
Today GW Pharmaceuticals has the market capitalization of 6.9B
How many employees does GW Pharmaceuticals have?▼
As of April 12, 2026, the company has 1,161 employees.
In which sector is GW Pharmaceuticals located?▼
GW Pharmaceuticals operates in the Manufacturing sector.
When did GW Pharmaceuticals complete a stock split?▼
GW Pharmaceuticals has not had any recent stock splits.
Where is GW Pharmaceuticals headquartered?▼
GW Pharmaceuticals is headquartered in Cambridge, United Kingdom.